$48.20 -1.27 (%) Sanofi Shs Sponsored American Deposit Receipt Repr 1/2 Sh - NYSE

Jul. 6, 2015 | 03:59 PM

Partner Headlines

  1. What Is Beyond Vision-Loss Blockbuster For Regeneron?

    IBD | Jul. 1, 2015 | 16:12PM EST
  2. Roche 'High Efficacy' MS Drug Succeeds In Trials

    IBD | Jun. 30, 2015 | 10:42AM EST
  3. Europe Stocks Plunge As Greece Shutters Banks

    IBD | Jun. 29, 2015 | 11:02AM EST
  4. Greece Fire: Eurozone Stocks Rally On Alleged Progress

    IBD | Jun. 22, 2015 | 17:36PM EST
  5. Top Europe Stocks Rally On Greece Bailout Hopes

    IBD | Jun. 22, 2015 | 15:17PM EST
  6. Alnylam Reports Data on Potential Alexion Rival Drug

    IBD | Jun. 12, 2015 | 12:38PM EST
  7. Isis, Biogen Rare-Disease Drug Aids Infant Survival

    IBD | Jun. 11, 2015 | 12:58PM EST
  8. Amgen Cholesterol Drug Repatha Wins FDA Panel Vote

    IBD | Jun. 10, 2015 | 17:35PM EST
  9. Regeneron, Amgen Fall On Cholesterol Drug Worries

    IBD | Jun. 10, 2015 | 11:44AM EST
  10. FDA Panel Clears Product Path For Sanofi, Regeneron Pharmaceuticals

    Benzinga | Jun. 10, 2015 | 10:52AM EST
  11. Stocks Poised For Strong Start; Qorvo Jumps In Premarket

    IBD | Jun. 10, 2015 | 08:50AM EST
  12. FDA Panel Backs Regeneron

    IBD | Jun. 9, 2015 | 18:51PM EST
  13. Regeneron/Sanofi Cholesterol Drug Wins FDA Panel Vote

    IBD | Jun. 9, 2015 | 18:09PM EST
  14. FDA Looking at New Drugs to Lower "Bad" Cholesterol

    FoxBusiness | Jun. 9, 2015 | 09:15AM EST
  15. FDA weighs cholesterol fighter

    IBD | Jun. 8, 2015 | 19:01PM EST
  16. FDA: Cholesterol Drug Works

    IBD | Jun. 5, 2015 | 18:38PM EST
  17. Regeneron/Sanofi Cholesterol Drug Under FDA Scrutiny

    IBD | Jun. 5, 2015 | 12:47PM EST
  18. Retrophin At All-Time High Levels on RE-024 FDA-Status; Syneron Settles Legal Battle

    GuruFocus | Jun. 5, 2015 | 12:40PM EST
  19. Will GlaxoSmithKline Cut Its 6% Dividend?

    GuruFocus | Jun. 3, 2015 | 15:32PM EST
  20. Research Can Be Key To Success For Tech Companies

    IBD | May. 29, 2015 | 16:53PM EST
  21. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 27, 2015 | 15:54PM EST
  22. Amgen's Cholesterol Fighting Drug Receives EU Approval

    GuruFocus | May. 26, 2015 | 16:46PM EST
  23. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 26, 2015 | 08:02AM EST
  24. Amgen gets cholesterol edge

    IBD | May. 22, 2015 | 18:21PM EST
  25. 3 Top IBD 50 Stocks Hit New All-Time Highs

    IBD | May. 21, 2015 | 16:36PM EST
  26. Move Over Chip Stocks: Here Are 5 Top Biotechs

    IBD | May. 20, 2015 | 09:34AM EST
  27. Move Aside, Chip Stocks, Biotechs Are Leaders Too

    IBD | May. 20, 2015 | 08:02AM EST
  28. Isis Pharma Up As Bayer Licenses Thrombosis Drug

    IBD | May. 4, 2015 | 13:03PM EST
  29. Warren Buffett's Top 10 Dividend Stocks with the Highest Yields

    GuruFocus | Apr. 25, 2015 | 15:24PM EST
  30. Dodge & Cox Stock Fund First Quarter 2015 Commentary

    GuruFocus | Apr. 24, 2015 | 17:34PM EST
  31. Genzyme Initiates Phase 2a Clinical Trial to Evaluate Oral Therapy for Fabry Disease

    Benzinga | Apr. 21, 2015 | 09:03AM EST
  32. Bristol-Myers scores again

    IBD | Apr. 17, 2015 | 19:01PM EST
  33. Bristol's Opdivo Scores Again Against Lung Cancer

    IBD | Apr. 17, 2015 | 16:14PM EST
  34. Bristol's Opdivo Scores Again Against Lung Cancer

    IBD | Apr. 17, 2015 | 10:44AM EST
  35. Making Money With Charles Payne: 04/10/15

    FoxBusiness | Apr. 10, 2015 | 18:00PM EST
  36. Dodge & Cox 2014 Equity Year in Review

    GuruFocus | Feb. 19, 2015 | 18:29PM EST
  37. Why Muscular Dystrophy Is Biotech's Favorite Orphan

    IBD | Feb. 19, 2015 | 16:59PM EST
  38. ENGAGE Randomized Clinical Trial Evaluating Cerdelgafor Treatment-Naïve Patients with Gaucher Disease Type 1 Published in The Journal of the American Medical Association

    Benzinga | Feb. 17, 2015 | 11:36AM EST
  39. Making Money With Charles Payne: 02/13/15

    FoxBusiness | Feb. 13, 2015 | 18:00PM EST
  40. Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea

    IBD | Feb. 10, 2015 | 10:30AM EST
  41. The Reasons That Make Pfizer A Worthy Hold.

    GuruFocus | Feb. 5, 2015 | 11:19AM EST
  42. Sanofi Posts Higher Q4 Profit

    Benzinga | Feb. 5, 2015 | 05:22AM EST
  43. Fourth Quarter Was Barrow's Slowest Since 2012

    GuruFocus | Feb. 4, 2015 | 17:48PM EST
  44. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Jan. 26, 2015 | 07:14AM EST
  45. Making Money With Charles Payne: 01/19/15

    FoxBusiness | Jan. 19, 2015 | 18:00PM EST
  46. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  47. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD | Jan. 13, 2015 | 19:06PM EST
  48. Cholesterol Drug Costs Eyed

    IBD | Jan. 13, 2015 | 18:51PM EST
  49. Griffin Securities Analyst Thinks New MannKind Management Will Focus On R&D, Not Sanofi Merger

    Benzinga | Jan. 12, 2015 | 15:44PM EST
  50. Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger

    Benzinga | Jan. 12, 2015 | 15:44PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!